PM
PharmaCyte Biotech, Inc.
PMCB · NASDAQ
$0.44 -3.83% (-$0.02)
1M -12.44%
Market Cap $4.41M
P/E Ratio -
Div. Yield -
ROE 60.42%
Piotroski F-Score Weak
2/9Valuation
90 /100
Cheap P/B 1.91x
P/FCF N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 2,751.79%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 45.90%
ROIC 83.13%
Debt
100 /100
Low Current ratio 40.30x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 250.18%
Profitable years 0
Beta 0.66x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PMCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua N. Silverman
Employees
2
Headquarters
Las Vegas
Evenimente viitoare
16 DEC.
Earnings
Upcoming earnings report